Blueprint Medicines | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Blueprint Medicines | 10-K: FY2024 Annual Report
Blueprint Medicines | 8-K: Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results
Blueprint Medicines | SCHEDULE 13G/A: Others
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Haviland Kate
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hurley Ariel
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 8-K: Current report
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 8-K: Current report
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hurley Ariel
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144